TARGETRIN THERAPEUTICS
Targetrin will develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP manufacturing capabilities of Cyclolab and EpiPharma’s proteomimetic peptide chemistry platform.
TARGETRIN THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Budapest, Budapest, Hungary
Country:
Hungary
Status:
Active